Next report date
Report period
Q1 2024
EPS estimate
−0.31EUR
Revenue estimate
31.96 MEUR
−129.65 MEUR
132.31 MEUR
107.03 M
Om Karyopharm Therapeutics Inc.
Sektor
Bransch
VD
Richard A. Paulson
Webbplats
Huvudkvarter
Newton
Employees (FY)
325
Grundat
2008
FIGI
BBG00645T1K4
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
